Matches in Wikidata for { <http://www.wikidata.org/entity/Q90307364> ?p ?o ?g. }
- Q90307364 description "2020 թվականի մարտի 11-ին հրատարակված գիտական հոդված" @default.
- Q90307364 description "article scientifique publié en 2020" @default.
- Q90307364 description "artykuł naukowy opublikowany 11 marca 2020" @default.
- Q90307364 description "artículu científicu espublizáu en marzu de 2020" @default.
- Q90307364 description "bài báo khoa học" @default.
- Q90307364 description "im März 2020 veröffentlichter wissenschaftlicher Artikel" @default.
- Q90307364 description "scientific article published on 11 March 2020" @default.
- Q90307364 description "wetenschappelijk artikel" @default.
- Q90307364 description "наукова стаття, опублікована 11 березня 2020" @default.
- Q90307364 name "Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Transglutaminase 2" @default.
- Q90307364 name "Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Transglutaminase 2" @default.
- Q90307364 type Item @default.
- Q90307364 label "Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Transglutaminase 2" @default.
- Q90307364 label "Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Transglutaminase 2" @default.
- Q90307364 prefLabel "Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Transglutaminase 2" @default.
- Q90307364 prefLabel "Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Transglutaminase 2" @default.
- Q90307364 P1433 Q90307364-200478ED-4C5D-474C-B145-00E83F926949 @default.
- Q90307364 P1476 Q90307364-BD1449B8-5667-4C30-8C6C-5EBD1F23DE32 @default.
- Q90307364 P2093 Q90307364-06A61897-959C-444D-B01C-FBB26798A40A @default.
- Q90307364 P2093 Q90307364-45709EBF-6BBA-483B-A651-0A49A2FD7F92 @default.
- Q90307364 P2093 Q90307364-DF7E2FBE-3597-4790-8404-EF65F7A52B13 @default.
- Q90307364 P2093 Q90307364-E95D4349-1ACE-403D-8F5A-177270C0578C @default.
- Q90307364 P275 Q90307364-3bc6250e-5039-4814-bd35-02dc3f04919f @default.
- Q90307364 P2860 Q90307364-0FD16BE8-F870-4464-A6FA-4C7AA8426940 @default.
- Q90307364 P2860 Q90307364-0FE62DD8-2EA4-4C25-B127-23C960B3E932 @default.
- Q90307364 P2860 Q90307364-126200F6-8ACE-49CB-B4CC-8314FF570FDD @default.
- Q90307364 P2860 Q90307364-2DC36E73-522F-4513-8AD5-61693040011B @default.
- Q90307364 P2860 Q90307364-2DD8C340-1BE6-40CA-B57E-38368EC3AF30 @default.
- Q90307364 P2860 Q90307364-31447BA2-4C70-4837-B680-6B040D8861E3 @default.
- Q90307364 P2860 Q90307364-32687271-C581-40C9-9094-1DF0A10B59D0 @default.
- Q90307364 P2860 Q90307364-3EFB0689-FD6B-4728-A0A8-5E4E6D58BD86 @default.
- Q90307364 P2860 Q90307364-4954E9C3-26AA-487D-9C2C-4416D4C80F3C @default.
- Q90307364 P2860 Q90307364-558E9A93-4E3D-450F-BF9A-B062805426C4 @default.
- Q90307364 P2860 Q90307364-56704D07-5310-41F6-A5E8-570C54429204 @default.
- Q90307364 P2860 Q90307364-5F41390A-B215-4005-99B5-CAEDF715DCA0 @default.
- Q90307364 P2860 Q90307364-696E7972-BE7C-477E-B96A-8E524ED04DEA @default.
- Q90307364 P2860 Q90307364-6B8C50D8-161C-4D5F-AD45-8C29ADF95D0B @default.
- Q90307364 P2860 Q90307364-6E5706CB-6EB1-4925-96BC-205736CE622C @default.
- Q90307364 P2860 Q90307364-71E82806-9972-47D4-A291-2DE08B30EBFB @default.
- Q90307364 P2860 Q90307364-9218AE39-6921-4232-BDC3-5DAB950DA9C1 @default.
- Q90307364 P2860 Q90307364-9D5CEC8E-4B23-46DB-A9F8-3D54F27E5378 @default.
- Q90307364 P2860 Q90307364-A3B7CD4E-48B3-4EF3-9090-6228436C5092 @default.
- Q90307364 P2860 Q90307364-B97A00B9-DC93-4C5A-B178-88FE1F0E17C0 @default.
- Q90307364 P2860 Q90307364-D3E2BE73-2F2D-45CC-8495-211C0ABAD588 @default.
- Q90307364 P2860 Q90307364-D6CB5388-6816-4609-84AE-7A90AF7B1F03 @default.
- Q90307364 P2860 Q90307364-E4D4D640-0D18-4D96-8FF2-AD77B86D2B63 @default.
- Q90307364 P2860 Q90307364-E4EAF7AF-305E-4938-B0EA-3160CC5C77F7 @default.
- Q90307364 P2860 Q90307364-EFA42E04-5177-43F1-9F74-616510868169 @default.
- Q90307364 P2860 Q90307364-F54471BB-4611-4388-94C7-1F057FC28E1D @default.
- Q90307364 P2860 Q90307364-FAEFDE2E-ECE1-4F85-8BD6-7FB229589595 @default.
- Q90307364 P2860 Q90307364-FB120233-2C32-473A-937E-71C918EF7CC7 @default.
- Q90307364 P2860 Q90307364-FE9E977A-DD02-4DD0-B65F-5EB8CCF033FC @default.
- Q90307364 P2860 Q90307364-FFA6422B-F31E-47D5-8114-356A57A77E10 @default.
- Q90307364 P31 Q90307364-AB8D4ABE-BF50-44DD-A764-971963FA4867 @default.
- Q90307364 P356 Q90307364-23094B3A-D574-4245-9D0A-D6B02F7B9966 @default.
- Q90307364 P433 Q90307364-0849C6D8-8DAB-48E3-B2AF-1680550355BD @default.
- Q90307364 P478 Q90307364-32414077-8C09-4424-9AD7-7E8601C9FC10 @default.
- Q90307364 P50 Q90307364-E3BA891B-7EBC-4DA6-A238-AEA9807F6E9A @default.
- Q90307364 P577 Q90307364-D6621376-F7FA-4BA0-8264-DC352F5C8938 @default.
- Q90307364 P6216 Q90307364-18d817d3-3417-4c5d-882b-708cb1f91ceb @default.
- Q90307364 P698 Q90307364-8C4F87D1-282D-42BE-966C-C5DC94D672B0 @default.
- Q90307364 P921 Q90307364-64C88FFA-4A9D-4368-9019-858CCAEE3BF5 @default.
- Q90307364 P921 Q90307364-70D4838B-5FD3-4259-9BF3-5579FBFD74D5 @default.
- Q90307364 P921 Q90307364-9C3D8380-1064-437B-8C9A-47888395DDC1 @default.
- Q90307364 P932 Q90307364-D3636138-08AC-4426-BCE1-CA98427D1BB0 @default.
- Q90307364 P356 CANCERS12030648 @default.
- Q90307364 P698 32168763 @default.
- Q90307364 P1433 Q27722963 @default.
- Q90307364 P1476 "Benefits of Combined All-Trans Retinoic Acid and Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia Cells and Further Enhancement by Inhibition of Atypically Expressed Transglutaminase 2" @default.
- Q90307364 P2093 "Iván P Uray" @default.
- Q90307364 P2093 "Jeffrey W Keillor" @default.
- Q90307364 P2093 "Károly Jambrovics" @default.
- Q90307364 P2093 "Zoltán Balajthy" @default.
- Q90307364 P275 Q20007257 @default.
- Q90307364 P2860 Q24605527 @default.
- Q90307364 P2860 Q26799862 @default.
- Q90307364 P2860 Q28069852 @default.
- Q90307364 P2860 Q28205648 @default.
- Q90307364 P2860 Q28260600 @default.
- Q90307364 P2860 Q28376006 @default.
- Q90307364 P2860 Q33551142 @default.
- Q90307364 P2860 Q33707936 @default.
- Q90307364 P2860 Q33728989 @default.
- Q90307364 P2860 Q34171631 @default.
- Q90307364 P2860 Q34404621 @default.
- Q90307364 P2860 Q34536380 @default.
- Q90307364 P2860 Q34563645 @default.
- Q90307364 P2860 Q34755208 @default.
- Q90307364 P2860 Q35205507 @default.
- Q90307364 P2860 Q36503511 @default.
- Q90307364 P2860 Q37700957 @default.
- Q90307364 P2860 Q37769807 @default.
- Q90307364 P2860 Q38341375 @default.
- Q90307364 P2860 Q39787475 @default.
- Q90307364 P2860 Q39798025 @default.
- Q90307364 P2860 Q40413191 @default.
- Q90307364 P2860 Q46301898 @default.
- Q90307364 P2860 Q47877010 @default.
- Q90307364 P2860 Q53743321 @default.
- Q90307364 P2860 Q55268558 @default.